$ENLV
Enlivex Ltd.
Nasdaq · Financial · Finance Services · Tel Aviv
ENLV chart
What traders are saying about $ENLV
Latest postsEnlivex Ltd. news
- Enlivex faces Nasdaq delisting risk, plans appeal
TradingView ·
- Enlivex receives Nasdaq delisting notice over bid price
Investing.com ·
- Enlivex receives Nasdaq delisting notice: what it means for Enlivex stock
ad-hoc-news.de ·
- Enlivex receives Nasdaq delisting notice over bid price By Investing.com
Investing.com Canada ·
- A prior reverse split leaves Enlivex (Nasdaq: ENLV) without a 180-day compliance window.
Stock Titan ·
- Enlivex receives Nasdaq delisting notice, executes 1-for-16 reverse split
StreetInsider ·
- Stock splits calendar for:
Yahoo Finance UK ·
- Enlivex announces 1-for-16 reverse split for Enlivex stock
ad-hoc-news.de ·
- Enlivex Ltd. (ENLV) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Enlivex Therapeutics Ltd (NASDAQ: ENLV) Stock Price, News & Analysis
kalkine.ca ·
- What Moved BayCom (NASDAQ:BCML), BranchOut Food (NASDAQ:BOF), Enlivex (NASDAQ:ENLV) and DarkIris (NASDAQ:DKI) on Company News?
Kalkine ·
- Enlivex announces 1-for-16 reverse stock split effective Oct. 27
Investing.com Nigeria ·
Enlivex Ltd. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $1.24B | -$15.0M | -$29.1M | -$31.1M |
| Diluted EPS | $25.48 | $-0.73 | $-1.56 | $-1.69 |
| Total assets (year end) | $2.33B | $27.7M | $36.8M | $67.6M |
| Cash and equivalents (year end) | $1.9M | $3.3M | $813,000 | $49.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
About Enlivex Ltd.
- Ticker
- ENLV (Nasdaq)
- Industry
- Finance Services
- Headquarters
- Tel Aviv
- Incorporated in
- Israel
- Fiscal year end
- December 31
- SEC CIK
- 1596812
- Former names
- Enlivex Therapeutics Ltd., Bioblast Pharma Ltd., BIO BLAST PHARMA LTD.
Frequently asked questions
What exchange is Enlivex Ltd. listed on?
Enlivex Ltd. trades on the Nasdaq under the ticker symbol ENLV.
What industry is Enlivex Ltd. in?
Enlivex Ltd. is classified by the SEC under "Finance Services", part of the Financial sector on StockTweeting.
Where is Enlivex Ltd. headquartered?
Enlivex Ltd.'s business address on file with the SEC is in Tel Aviv.
When does Enlivex Ltd.'s fiscal year end?
Enlivex Ltd.'s fiscal year ends on December 31.